AnterogenCoLtd (Korea) Performance
| 065660 Stock | KRW 15,230 540.00 3.42% |
The firm shows a Beta (market volatility) of 0.34, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AnterogenCoLtd's returns are expected to increase less than the market. However, during the bear market, the loss of holding AnterogenCoLtd is expected to be smaller as well. At this point, AnterogenCoLtd has a negative expected return of -0.0281%. Please make sure to confirm AnterogenCoLtd's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if AnterogenCoLtd performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Over the last 90 days AnterogenCoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, AnterogenCoLtd is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -14.4 B |
AnterogenCoLtd |
AnterogenCoLtd Relative Risk vs. Return Landscape
If you would invest 1,570,000 in AnterogenCoLtd on August 24, 2024 and sell it today you would lose (47,000) from holding AnterogenCoLtd or give up 2.99% of portfolio value over 90 days. AnterogenCoLtd is generating negative expected returns and assumes 2.1865% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than AnterogenCoLtd, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AnterogenCoLtd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AnterogenCoLtd's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AnterogenCoLtd, and traders can use it to determine the average amount a AnterogenCoLtd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0129
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 065660 |
Estimated Market Risk
| 2.19 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AnterogenCoLtd is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AnterogenCoLtd by adding AnterogenCoLtd to a well-diversified portfolio.
AnterogenCoLtd Fundamentals Growth
AnterogenCoLtd Stock prices reflect investors' perceptions of the future prospects and financial health of AnterogenCoLtd, and AnterogenCoLtd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AnterogenCoLtd Stock performance.
| Return On Equity | -5.92 | |||
| Return On Asset | -0.0231 | |||
| Profit Margin | (1.32) % | |||
| Operating Margin | (0.77) % | |||
| Current Valuation | 836.51 B | |||
| Shares Outstanding | 7.95 M | |||
| Price To Sales | 103.53 X | |||
| Revenue | 8.12 B | |||
| EBITDA | (2.96 B) | |||
| Cash And Equivalents | 6.97 B | |||
| Debt To Equity | 43.70 % | |||
| Cash Flow From Operations | (3.05 B) | |||
| Total Asset | 136.7 B | |||
About AnterogenCoLtd Performance
By analyzing AnterogenCoLtd's fundamental ratios, stakeholders can gain valuable insights into AnterogenCoLtd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AnterogenCoLtd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AnterogenCoLtd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about AnterogenCoLtd performance evaluation
Checking the ongoing alerts about AnterogenCoLtd for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AnterogenCoLtd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AnterogenCoLtd generated a negative expected return over the last 90 days | |
| The company reported the revenue of 8.12 B. Net Loss for the year was (553.98 M) with profit before overhead, payroll, taxes, and interest of 1.72 B. | |
| AnterogenCoLtd has accumulated about 6.97 B in cash with (3.05 B) of positive cash flow from operations. | |
| Roughly 21.0% of the company shares are owned by insiders or employees |
- Analyzing AnterogenCoLtd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AnterogenCoLtd's stock is overvalued or undervalued compared to its peers.
- Examining AnterogenCoLtd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AnterogenCoLtd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AnterogenCoLtd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AnterogenCoLtd's stock. These opinions can provide insight into AnterogenCoLtd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AnterogenCoLtd Stock analysis
When running AnterogenCoLtd's price analysis, check to measure AnterogenCoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnterogenCoLtd is operating at the current time. Most of AnterogenCoLtd's value examination focuses on studying past and present price action to predict the probability of AnterogenCoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnterogenCoLtd's price. Additionally, you may evaluate how the addition of AnterogenCoLtd to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |